Breaking News Instant updates and real-time market news.

KPTI

Karyopharm

$17.95

-0.55 (-2.97%)

04:55
08/16/18
08/16
04:55
08/16/18
04:55

Karyopharm management to meet with Jefferies

Meeting to be held in Boston in August 16 hosted by Jefferies.

  • 16

    Aug

KPTI Karyopharm
$17.95

-0.55 (-2.97%)

05/24/18
WEDB
05/24/18
DOWNGRADE
WEDB
Neutral
Karyopharm downgraded to Neutral from Outperform at Wedbush
05/24/18
05/24/18
DOWNGRADE
Target $19

Neutral
Karyopharm downgraded to Neutral at Wedbush
As previously reported, Wedbush analyst David Nierengarten downgraded Karyopharm to Neutral from Outperform on valuation. The analyst also lowered his price target on the shares to $19 from $20 as he updates his model for the company's offering and for a somewhat shorter duration of therapy based on the STORM duration of response of 4.4 months.
05/24/18
HCWC
05/24/18
NO CHANGE
Target $30
HCWC
Buy
H.C. Wainwright remains bullish Karyopharm after STORM data, license deal
H.C. Wainwright analyst Edward White reiterates a Buy rating and $30 price target for Karyopharm, while pointing out that recent positive Phase 2b STORM data confirmed his expectations for the success of selinexor. The company expects a NDA submission for an accelerated approval of selinexor in patients with penta-refractory multiple myeloma in 2H18, he says, adding that he estimates the addressable peak market size for this population is over $500M in the U.S. The analyst also notes that the company has announced an exclusive license agreement for the development and commercialization of selinexor, eltanexor, verdinexor and KPT-9274 with Antengene Corporation.
05/24/18
05/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AbbVie (ABBV) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jami Rubin citing share outperformance. 2. Petrobras (PBR) downgraded to Equal Weight from Overweight at Morgan Stanley, to Neutral from Outperform at Credit Suisse, to Neutral from Buy at BofA/Merrill, and to Market Perform from Outperform at Itau BBA. 3. Karyopharm (KPTI) downgraded to Neutral from Outperform at Wedbush with analyst David Nierengarten citing valuation. 4. Vermillion (VRML) downgraded to Hold from Buy at Canaccord. 5. Generac (GNRC) downgraded to Neutral from Outperform at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MU

Micron

$46.06

1.01 (2.24%)

16:52
09/20/18
09/20
16:52
09/20/18
16:52
Hot Stocks
Micron says it achieved record revenue in FY18 »

Says expects 1ynm sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:45
09/20/18
09/20
16:45
09/20/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$24.82

0.17 (0.69%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Teva initiated  »

Teva assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Crispr Therapeutics initiated  »

Crispr Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Intellia Therapeutics initiated  »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated  »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:42
09/20/18
09/20
16:42
09/20/18
16:42
Syndicate
Western Asset Mortgage 6.5M share Spot Secondary; price range $10.85-$11.10 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Initiation
Vanda Pharmaceuticals initiated  »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WYNN

Wynn Resorts

$137.32

1.64 (1.21%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Lone Pine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell is in…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPVG

TriplePoint Venture

$12.97

-0.01 (-0.08%)

16:39
09/20/18
09/20
16:39
09/20/18
16:39
Initiation
TriplePoint Venture initiated  »

TriplePoint Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$4.70

-0.25 (-5.05%)

16:38
09/20/18
09/20
16:38
09/20/18
16:38
Initiation
KemPharm initiated  »

KemPharm assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLL

Ball Corp.

$44.39

0.15 (0.34%)

16:35
09/20/18
09/20
16:35
09/20/18
16:35
Hot Stocks
Ball Corp. CFO Scott Morrison sells over $1M in company shares »

Ball Corp. CFO Scott…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLIT

Harmonic

$5.20

0.15 (2.97%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Initiation
Harmonic initiated  »

Harmonic initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

, AAPL

Apple

$220.00

1.655 (0.76%)

16:33
09/20/18
09/20
16:33
09/20/18
16:33
Periodicals
Twitch appears to be blocked in China, Abacus reports »

Amazon's (AMZN)…

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

AAPL

Apple

$220.00

1.655 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$70.79

0.8 (1.14%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Hot Stocks
Merck receives positive CHMP opinion for DELSTRIGO and PILFETRO in E.U. »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

16:30
09/20/18
09/20
16:30
09/20/18
16:30
Options
Preliminary option volume of 24.2M today »

Preliminary option volume…

INDB

Independent Bank

$89.85

0.65 (0.73%)

, BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Hot Stocks
Independent Bank to acquire Blue Hills Bancorp »

Independent Bank (INDB),…

INDB

Independent Bank

$89.85

0.65 (0.73%)

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for holders »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for UWW Holdings, LLC »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$14.02

0.67 (5.02%)

16:26
09/20/18
09/20
16:26
09/20/18
16:26
Syndicate
Fate Therapeutics $100M Spot Secondary; re-offered at $13.50 »

Jefferies, Piper Jaffray…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.